跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 394 条关于
“NCTx”
全部
394
临床试验
182
药物
185
机构
1
资讯
26
去年
eXoZymes Achieves Breakthrough in NCT Production with AI-Driven Biomanufacturing Platform
去年
CIT Therapeutics Secures $2.5M Partnership with IFLI to Advance Novel SUMOylation-Targeted Cancer Therapy
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
去年
Neurona's NRTX-1001 Cell Therapy Advances to Phase 3 Trial for Drug-Resistant Epilepsy
去年
Compass Therapeutics' CTX-471 Shows Promise with NCAM Biomarker Correlation in Advanced Malignancies
2年前
FDA Clears Path for Cingulate's CTx-1301 ADHD Treatment NDA Submission
去年
Nicox Secures $16.5 Million Financing to Advance NCX 470 Glaucoma Trial
2年前
Nicox Completes U.S. Recruitment for Phase 3 Glaucoma Trial of NCX 470
去年
Compass Therapeutics Receives FDA Fast Track Designation for CTX-009 Bispecific Antibody
2个月前
Epigenetic Therapy NTX-301 Activates Hippo Pathway to Overcome Treatment-Resistant AML
第 1 页,共 3 页
上一页
下一页